Tumor associated sleep disorder
Conditions
Interventions
control group :Sedative hypnotic drugs
Experimental group:Sedative hypnotic drugs +Chinese traditional medicine(TCM)
Sponsors
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as malignant tumors by pathological diagnosis; 2. Have typical insomnia symptoms, meet the diagnostic criteria of Western medicine, and the PSQI score is greater than 7; 3. Female, aged from 18 to 75 years (including both sides), with stable vital signs, expected survival of more than 6 months, and clear consciousness; 4. The patients had no major organ dysfunction or pain, and the NRS score was 0-3; 5. Those who have taken sedative and hypnotic drugs (estazolam tablets or zolpidem tablets) for no more than 1 month before enrollment. 6. Understand and agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Have serious diseases such as heart, liver, kidney and hematopoietic system, pregnant or lactating patients, and have a history of mental illness that is difficult to control; ? 2. Patients with intracranial tumors and cognitive impairment; 3. Known allergy to the ingredients of this traditional Chinese medicine; 4. Participating in clinical trials of other drugs or within 4 weeks; 5. Patients who received tumor related surgery, chemotherapy or radiotherapy in recent 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index, PSQI; | — |
Countries
China
Contacts
Public ContactChai Ni
Outcome results
None listed